Global /India /Healthcare /Drug Manufacturers - General /536565

Novelix Pharmaceuticals Ltd.

536565 (NOVELIX)

• BSE: 536565 • Delayed

55.95INR 0.8%

0.5934 USD

As of 25 June 2026, Novelix Pharmaceuticals Ltd. has a market cap of $11.68M USD, ranking #40401 globally and #3123 in India. It ranks #3601 in the Healthcare sector, and #1176 in the Drug Manufacturers - General industry.

Global Rank

40401

Country Rank

3123

Sector Rank

3601

Industry Rank

1176

Key Stats

Market Cap

$11.68MUSD

1.11B INR

Enterprise Value

$11.59MUSD

1.09B INR

Revenue (TTM)

$13.51MUSD

1.28B INR

EBITDA (TTM)

$256.97KUSD

24.23M INR

Net Income (TTM)

$190.57KUSD

18.06M INR

EBITDA Margin

1.9%

Profit Margin

1.4%

PE Ratio

46.3

PS Ratio

0.9

PB Ratio

4.3

EV/EBITDA

45.1

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Venkateshwarlu Pulluru open_in_new

Employees

Founded

1994

Website

novelixpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	0.8%	-0.4%	-6%	6.2%	-11%	109%	501%	659%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	536565 (NOVELIX) Novelix Pharmaceuticals Ltd ISIN: INE314I01036 Shares Out.: Shares Outstanding: 21.085M¹ TV: TradingView: BSE: NOVELIX SA: Stock Analysis: BOM: 536565 YF: Yahoo Finance: 536565.BO GF: Google Finance: BOM: 536565 BA: Barron's: 536565 MS: Morningstar: XBOM: 536565	55.95 INR	TV: TradingView: BSE: NOVELIX SA: Stock Analysis: BOM: 536565 YF: Yahoo Finance: 536565.BO GF: Google Finance: BOM: 536565 BA: Barron's: 536565 MS: Morningstar: XBOM: 536565

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Novelix Pharmaceuticals Ltd.

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.04B 4.27T INR 385K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.31B 1.73T INR 157K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.11B 1.43T INR 129K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.69B 1.11T INR 100K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.83B 931.67B INR 84K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.67B 916.53B INR 83K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 7M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 5M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 3M%	97.4	United States
Roche Holding AG SIX: RO	$316.37B 256.25B CHF 3M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.33B 215.59B GBP 2M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 2M%	15.1	United States

chevron_leftBack